Next Generation News and Research

RSS

UH scientist evaluates microRNAs as potential treatment strategy for ovarian cancer

The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.

22 Dec 2010

Pepex announces development of combined glucose monitoring and insulin delivery meter

Pepex Biomedical, Inc. has unveiled development of a next generation solution for insulin dependent diabetics which will combine regular glucose monitoring and insulin delivery for diabetes sufferers worldwide. The company is developing a complete product line of multi-function meters which allow simple testing of blood glucose levels and insulin delivery, appropriate to each glucose level measurement, all contained in a single, palm-sized unit. These meters provide anytime, anywhere tracking and treatment of diabetes.

22 Dec 2010

Health-care coverage program for kids ends in Ariz.; Florida Medicaid patient information may be at risk

A new audit criticizes the Florida Agency for Health Care Administration and a contractor for failing to properly control access to computer systems that include sensitive information about Medicaid beneficiaries (Saunders, 12/17).

20 Dec 2010

Isotechnika, Paladin receive screening acceptance for Voclera for approval in Canada

Isotechnika Pharma Inc. and Paladin Labs Inc. announced today that they have submitted the dossier and received screening acceptance for VocleraTM (voclosporin) for approval in the Canadian market. VocleraTM is a novel immunosuppressive drug in the class of calcineurin inhibitors and is indicated for the treatment of moderate to severe psoriasis.

20 Dec 2010

EMA grants SME designation to PROLOR Biotech

PROLOR Biotech, Inc.,, a clinical stage company developing next generation biobetter therapeutic proteins, today announced that the European Commission and the European Medicines Agency (EMA) has granted PROLOR the designation of "Small and Medium Sized Enterprise" (SME).

20 Dec 2010

Sanofi-aventis, Oxford University to conduct multi-phase oncology research in India

Sanofi-aventis US and Oxford University have entered into an agreement to conduct multi-phase oncology clinical and epidemiological research with INDOX, India's leading academic oncology network.

20 Dec 2010

$FDA approves Medtronic's Arctic Front Cardiac CryoAblation Catheter system for drug refractory PAF$

FDA approves Medtronic's Arctic Front Cardiac CryoAblation Catheter system for drug refractory PAF

Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Arctic Front® Cardiac CryoAblation Catheter system, the first and only Cryoballoon in the United States indicated for the treatment of drug refractory paroxysmal atrial fibrillation (PAF). The Cryoballoon treatment involves a minimally-invasive procedure that efficiently creates circumferential lesions around the pulmonary vein, which is the source of erratic electrical signals that cause the irregular heartbeat.

20 Dec 2010

Arthrosurface conducts first knee procedure based on HemiCAP platform technology

Arthrosurface, Inc., the developer of less-invasive joint resurfacing systems, announced that it has performed its first biological knee procedure based on the company's proven HemiCAP® platform technology.

19 Dec 2010

Cancer Treatment Centers of America deploys Intel's personal health system solution

Cancer Treatment Centers of America (CTCA) is deploying the Intel® Health Guide - a next-generation personal health system solution that allows physicians and clinicians to proactively monitor their patients' care at home - as part of its commitment to provide patients with the information and resources they need to make educated decisions about their cancer care.

17 Dec 2010

Epitomics enters contract with SAIC Frederick to develop rabbit monoclonal antibodies for CPTC program

Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).

16 Dec 2010

RPCI forms Photolitec to develop photosensitizing compounds used in photodynamic therapy

Roswell Park Cancer Institute (RPCI) on December 13, 2010, announced the formation of Photolitec, LLC, a new life-sciences company at RPCI that will develop photosensitizing compounds used in photodynamic therapy (PDT). PDT is an innovative cancer treatment pioneered at RPCI by scientist Thomas J. Dougherty, Chief Emeritus of the Institute's Photodynamic Therapy Center.

15 Dec 2010

Anoles key to medically applicable regeneration?

Anolis lizards first entered Arizona State University biologist Kenro Kusumi's life in 1980 when, as a member of a junior curator program, he recorded in his field notebook that he had found an Anolis egg on a field trip. Kusumi still has those notes, along with other memorabilia that document the influence that both his early life and more recent experiences have had on his current pursuits in developmental biology.

15 Dec 2010

New skincare product with cellular activators

Scientists in Iceland have developed a revolutionary skincare product after more than a decade of extensive research in plant biotechnology. The skin-rejuvenating phenomenon is called BIOEFFECT(TM) EGF Serum. Made by Sif Cosmetics, it is the world's first skincare product to contain cellular activators made in plants. Six months after its launch in Iceland, the serum is already being used by over 20% of Icelandic women.

15 Dec 2010

AzTe and Zcube: Innovative treatment of chronic respiratory diseases

Zcube, Srl, the research venture of Italian pharmaceutical company Zambon Co., SpA, and Arizona Technology Enterprises (AzTE), the technology venturing arm of Arizona State University, have entered into a licensing agreement that will allow Zcube to use ASU technology to develop and commercialize next-generation medical devices that can better monitor and treat chronic respiratory diseases like asthma.

15 Dec 2010

Smiths Medical launches Medfusion 4000 wireless syringe infusion pump with PharmGuard systems in Canada

Smiths Medical, a leading global medical device manufacturer, announced today it received a license from Health Canada and launched its Medfusion® 4000 syringe infusion pump with the PharmGuard® software suite in Canada. The new customizable system allows health care providers to send and receive medication delivery information more efficiently, helping to prevent medication errors.

15 Dec 2010

Synergetics launches next generation of Codman Malis electrosurgical generator

Synergetics USA, Inc., a medical device company that designs, manufactures, and markets innovative products for ophthalmic and neurosurgical applications, has introduced the CMC® V, the next generation of the Codman® Malis® electrosurgical generator. Codman & Shurtleff, Inc. is the exclusive distributor of the CMC® V. CMC and Codman are registered trademarks of Johnson & Johnson Corporation.

15 Dec 2010

Study explores meaning of respect in medical student education

Along with integrity and compassion, respect for patients, colleagues and other team members is an essential attribute of medical professionalism. A new study examines how medical students learn respectful or disrespectful professional behavior.

14 Dec 2010

Life Technologies announces launch of Ion Personal Genome Machine sequencer

Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has launched its Ion Personal Genome Machine (PGM™) sequencer, the first product to use semiconductor sequencing technology. The sequencer is shipping to select sites in North America, Europe and Asia Pacific.

14 Dec 2010

Mouse study shows flu virus infection may protect against asthma

In a paper that suggests a new strategy to prevent asthma, scientists at Children's Hospital Boston and their colleagues report that the influenza virus infection in young mice protected the mice as adults against the development of allergic asthma.

14 Dec 2010

Cedarlane to distribute TGR's new ELISA-One technology assay reagents in Canada and the US

TGR BioSciences, a leading global provider of advanced cell based assay technologies in the fields of cancer, kinase and GPCR research, is extremely pleased to announce a distribution partnership with Cedarlane Laboratories of Burlington, ON, Canada, a leading supplier of Life Science research reagents in North America.

13 Dec 2010

Next Generation News and Research

UH scientist evaluates microRNAs as potential treatment strategy for ovarian cancer

Pepex announces development of combined glucose monitoring and insulin delivery meter

Health-care coverage program for kids ends in Ariz.; Florida Medicaid patient information may be at risk

Isotechnika, Paladin receive screening acceptance for Voclera for approval in Canada

EMA grants SME designation to PROLOR Biotech

Sanofi-aventis, Oxford University to conduct multi-phase oncology research in India

FDA approves Medtronic's Arctic Front Cardiac CryoAblation Catheter system for drug refractory PAF

Arthrosurface conducts first knee procedure based on HemiCAP platform technology

Cancer Treatment Centers of America deploys Intel's personal health system solution

Epitomics enters contract with SAIC Frederick to develop rabbit monoclonal antibodies for CPTC program

RPCI forms Photolitec to develop photosensitizing compounds used in photodynamic therapy

Anoles key to medically applicable regeneration?

New skincare product with cellular activators

AzTe and Zcube: Innovative treatment of chronic respiratory diseases

Smiths Medical launches Medfusion 4000 wireless syringe infusion pump with PharmGuard systems in Canada

Synergetics launches next generation of Codman Malis electrosurgical generator

Study explores meaning of respect in medical student education

Life Technologies announces launch of Ion Personal Genome Machine sequencer

Mouse study shows flu virus infection may protect against asthma

Cedarlane to distribute TGR's new ELISA-One technology assay reagents in Canada and the US

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News